- Business Wire•9 days ago
InVivo Therapeutics Announces Oral Presentations at the 2017 American Spinal Injury Association Annual Scientific Meeting
InVivo Therapeutics Holdings Corp. today announced that the company will be giving two oral presentations at the 2017 American Spinal Injury Association Annual Scientific Meeting to be held April 26-29, 2017 in Albuquerque, New Mexico.
- Business Wire•19 days ago
InVivo Therapeutics Holdings Corp. today announced that the Brigham and Women’s Hospital in Boston, MA has been added as a clinical site for The INSPIRE Study: InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold™ for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury.
- Business Wire•24 days ago
InVivo Therapeutics Announces New Patient Enrollment into the INSPIRE Study at the Carolinas Medical Center
InVivo Therapeutics Holdings Corp. today announced that a new patient has been enrolled into The INSPIRE Study at the Carolinas Medical Center in Charlotte, NC.
NVIV : Summary for InVivo Therapeutics Holdings Co - Yahoo Finance
InVivo Therapeutics Holdings Corp. (NVIV)
Other OTC - Other OTC Real Time Price. Currency in USD
Add to watchlist
|Ask||6.25 x 700|
|Day's Range||3.70 - 3.95|
|52 Week Range||3.30 - 7.94|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-5.00|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|